China Sky One Medical reported that it has 11 new drugs in clinical trials, seven of them administered by injection. The clinical trials are expected to be underway for six months. Assuming the trials are successful, China Sky One projects it will submit the drugs for SFDA approval in early 2009. China Sky One has traditionally emphasized externally administered products (patches and ointments), but it has been building up its product portfolio by acquiring other companies. More details...

Stock Symbol: (AMEX: CSY)